AMRI to Announce First Quarter Results

AMRI (NASDAQ:AMRI) will report first quarter results after the close of the market on Wednesday, May 6, 2009. The company will subsequently hold a conference call on Thursday, May 7, 2009 at 10 a.m. EDT to discuss quarterly financial results.

To listen to the conference call, dial 877-719-9799 (for domestic calls) or 719-325-4791 (for international calls) at 9:45 a.m. EDT and provide conference code 3568646. In addition, the call is being webcast on the Internet and can be accessed on the company's website, www.amriglobal.com.

Replays of the call will be available for seven days following the call beginning at noon on May 7, 2009. To access the replay by telephone, dial 888-203-1112 (for domestic calls) or 719-457-0820 (for international calls) and use passcode 3568646. Replays of the call will also be available as a webcast for three months in the investor area of the company's website at www.amriglobal.com/investor_relations/.

Founded in 1991, Albany Molecular Research, Inc. (AMRI) provides scientific services, products and technologies focused on improving the quality of life. AMRI works on drug discovery and development projects and conducts manufacturing of active ingredients and pharmaceutical intermediates for many of the world's leading healthcare companies. As an additional value added service to its customers, the company is also investing in R&D in order to expand its contract services and to identify novel early stage drug candidates with the goal to outlicense to a strategic partner. With locations in the U.S., Europe, and Asia, AMRI provides customers with a wide range of services, technologies and cost models.